Trial intelligence / Profile preview

Rifampin versus azithromycin for verruga peruana

ISRCTN16597283Phase 4Completed

Sponsor
Uniformed Services University of the Health Sciences
Start
Jun 2003
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, open-label trial in bartonellosis and Carrion's disease comparing Rifampin with Azithromycin (2 arms). Primary endpoints: Time to resolution of verrucous lesions and Time to resolution of Bartonella bacteremia. Started Jun 2003; status: completed.

02

Drugs

rifampicinazithromycin
03

Conditions

bartonellosisCarrion's disease

Beyond the preview

Go deeper on ISRCTN16597283.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ISRCTN16597283.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call